Headache

PROMISE-1 & PROMISE-2: eptinezumab in episodic and chronic migraine 1:08
PROMISE-1 & PROMISE-2: eptinezumab in episodic and chronic migraine
Rami Apelian • 21 Jun 2022
The role of stigma in migraine-related disability and quality of life 1:55
The role of stigma in migraine-related disability and quality of life
Elizabeth Seng • 15 Jun 2022
Treating migraines in patients not responding to CGRP monoclonal antibodies 1:55
Treating migraines in patients not responding to CGRP monoclonal antibodies
Simona Sacco • 26 Jun 2022
The NIH priorities for migraine research 1:02
The NIH priorities for migraine research
Michael Oshinsky • 15 Jun 2022
Neuronal complexity in migraine and peripheral pain models 4:18
Neuronal complexity in migraine and peripheral pain models
Amynah Pradhan • 15 Jun 2022
Increased placebo response over time in migraine preventive trials 5:55
Increased placebo response over time in migraine preventive trials
Stewart Tepper • 17 Jun 2022
The NIH roadmap for headache research 1:12
The NIH roadmap for headache research
Michael Oshinsky • 15 Jun 2022
Social stigma in the migraine population 2:56
Social stigma in the migraine population
Elizabeth Seng • 15 Jun 2022
The current state of pediatric headache research 4:46
The current state of pediatric headache research
Serena Orr • 14 Jun 2022
How to effectively incorporate PROMs into migraine clinical practice and trials 3:03
How to effectively incorporate PROMs into migraine clinical practice and trials
Richard Lipton • 13 Jun 2022
For or against? Anti-CGRP monoclonal antibodies as a first-line therapy for migraines 4:05
For or against? Anti-CGRP monoclonal antibodies as a first-line therapy for migraines
Simona Sacco • 26 Jun 2022
Clinician-patient dialogue in headache care 0:58
Clinician-patient dialogue in headache care
Simona Sacco • 26 Jun 2022
Real-world studies show effectiveness of anti-CGRP mAbs in difficult to treat patients with migraine 3:19
Real-world studies show effectiveness of anti-CGRP mAbs in difficult to treat patients with migraine
Messoud Ashina • 23 Jun 2022
Unmet needs in migraine: addressing inter-ictal burden 1:51
Unmet needs in migraine: addressing inter-ictal burden
Uwe Reuter • 25 Jun 2022
Latest guidelines on anti-CGRP antibodies: first-line and long-term use 2:24
Latest guidelines on anti-CGRP antibodies: first-line and long-term use
Messoud Ashina • 23 Jun 2022
Current and future work on migraine pathophysiology research 3:17
Current and future work on migraine pathophysiology research
Bojana Žvan • 22 Mar 2022
The content of VJNeurology is intended for healthcare professionals